TARSUS PHARMACEUTICALS, INC. (TARS) Operating margin 2021–2025
TARSUS PHARMACEUTICALS, INC. (TARS) operating margin by fiscal year — reported operating income divided by reported revenue.
-15.7%FY2025 · since FY2021: -21.3% → -15.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -15.7% | +50.2 pp |
| FY2024 | -65.9% | +754.6 pp |
| FY2023 | -820.5% | -577.6 pp |
| FY2022 | -242.9% | -221.6 pp |
| FY2021 | -21.3% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TARS financial trends
TARS RevenueTARS Net incomeTARS Net marginTARS Gross profitTARS Gross marginTARS Operating incomeTARS Operating cash flowTARS Free cash flowTARS Capital expendituresTARS Return on equityTARS Stock buybacksTARS Dividends paidTARS Total assetsTARS Total liabilitiesTARS Shareholders’ equityTARS overview →